Home・Lista de Ações・Travere Therapeutics Inc

Travere Therapeutics Inc

Fechado

61.32 -1.72

Comprar Vender

Visão Geral

Variação de preço das ações

24h

Atual

Mín

60.52

Máximo

63.29

Indicadores-chave
By Trading Economics
Rendimento	-15M -37M
Vendas	-2.5M 127M
EPS	0.05
Margem de lucro	-28.775
Funcionários	497
EBITDA	-8.6M -9.2M

Recomendações
By TipRanks
Recomendações	Compra Forte
Previsão para 12 meses	+15.69% upside

Dividendos
By Acuity
Próximos Ganhos	29 de out. de 2026

Estatísticas de Mercado
By TradingEconomics
Capitalização de Mercado	1.3B 5.1B
Abertura anterior	63.04
Fecho anterior	61.32

Travere Therapeutics Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

7 de ago. de 2026, 23:56 UTC

Correlated Moves

American Water Works shows little change in after-market trading, remaining near the upper end of its one-month range amid reduced rate hike concerns.

7 de ago. de 2026, 23:56 UTC

Lululemon Athletica shares are higher in after-market hours, continuing a trend of four consecutive sessions above the 20-day moving average. No specific news was identified.

7 de ago. de 2026, 23:56 UTC

Crown Holdings Inc shares are lower in after-market hours, continuing a downward trend amid decreased expectations for immediate Federal Reserve interest rate hikes.

7 de ago. de 2026, 23:56 UTC

Arcosa Inc shares declined slightly in after-market trading, remaining near the lower end of their one-month trading range. No specific news was identified.

7 de ago. de 2026, 23:56 UTC

No specific news for Synchrony Financial as after-market trading remains roughly flat. The stock is above its 20-day moving average and near its one-month high.

7 de ago. de 2026, 23:56 UTC

Correlated Moves

Insteel Industries Inc. shares remained roughly flat in after-market hours, reflecting broader market dynamics and the impact of Federal Reserve interest rate considerations.

7 de ago. de 2026, 23:56 UTC

Atkore Inc. shares declined after-market, retracing from an initial peak post-close. The stock remains near the upper end of its one-month range.

7 de ago. de 2026, 23:56 UTC

Academy Sports and Outdoors Inc. shares are roughly flat in after-market trading, with no specific news driving the minimal movement since Friday's close.

7 de ago. de 2026, 23:56 UTC

Correlated Moves

Snap-On Inc shares are higher in after-market trading, reflecting strong interest and aligning with broader market trends. The stock remains above its 20-day moving average.

7 de ago. de 2026, 23:56 UTC

Correlated Moves

Waters Corp shares declined in after-market trading, following a broader trend influenced by recent economic data and a weak jobs report.

7 de ago. de 2026, 23:56 UTC

Cerus Corp shares are higher in after-market trading, recovering from earlier declines amid shifting expectations for Federal Reserve interest rate hikes.

7 de ago. de 2026, 23:56 UTC

Marriott International shares are higher in after-market trading, though no specific news was identified to explain the movement. The stock remains below its 20-day moving average.

7 de ago. de 2026, 23:56 UTC

Ensign Group Inc. shares traded roughly flat in after-market hours, reflecting minor adjustments amid Federal Reserve interest rate outlook concerns following a weak jobs report.

7 de ago. de 2026, 23:56 UTC

Brady Corp shares are higher in after-market trading, reflecting a modest gain since Friday's close and positioning above its 20-day moving average.

7 de ago. de 2026, 23:56 UTC

American States Water Co. shares traded roughly flat after hours amid broader market concerns about the Federal Reserve's interest rate policies following a weak jobs report.

7 de ago. de 2026, 23:56 UTC

Axos Financial Inc. shares were roughly flat in after-market trading amid broader market concerns over potential Federal Reserve interest rate hikes.

7 de ago. de 2026, 23:56 UTC

Toro Co shares traded with little change during after-market hours, fluctuating within a narrow range. The stock remains above its 20-day moving average.

7 de ago. de 2026, 23:56 UTC

NAPCO Security Technologies traded roughly flat in after-market hours, remaining significantly above its 20-day moving average after seven consecutive sessions of higher closes.

7 de ago. de 2026, 23:56 UTC

Bio Rad Laboratories Inc. shares declined in after-market trading, reflecting routine fluctuations. The stock remains above its 20-day moving average.

7 de ago. de 2026, 23:56 UTC

ABM Industries shares showed routine trading activity after market hours, fluctuating slightly around Friday's close and remaining near the upper end of its one-month range.

7 de ago. de 2026, 23:56 UTC

Equifax Inc. shares were roughly flat during after-market hours, trading near the upper end of their one-month range. No specific news was identified.

7 de ago. de 2026, 23:56 UTC

Correlated Moves

Steven Madden Ltd traded roughly flat in after-market hours, reflecting broader market trends amid tempered expectations for Federal Reserve interest rate hikes.

7 de ago. de 2026, 23:56 UTC

Prestige Consumer Healthcare Inc. shares traded roughly flat after-market hours, following six consecutive higher daily closes and remaining above its 20-day moving average.

7 de ago. de 2026, 23:56 UTC

Shares of LTC Properties Inc. are higher in after-market hours, influenced by decreased expectations for immediate interest rate hikes following a weak jobs report.

7 de ago. de 2026, 23:56 UTC

Correlated Moves

News Corp shares gained slightly in after-market trading, supported by a favorable market environment following a weak jobs report and decreased rate hike expectations.

7 de ago. de 2026, 23:56 UTC

PJT Partners Inc shares are higher in after-market trading, despite no specific news. A weaker jobs report may be influencing investor sentiment.

7 de ago. de 2026, 23:56 UTC

UDR Inc shares declined in after-market trading, reflecting broader market concerns over potential Federal Reserve interest rate hikes amid weak job data.

7 de ago. de 2026, 23:56 UTC

Correlated Moves

Whirlpool Corp shares rose in after-market trading, reflecting broader market trends and decreased expectations for immediate interest rate hikes following a weak jobs report.

7 de ago. de 2026, 23:56 UTC

Universal Health Services Inc. shares are lower in after-market trading, reflecting routine performance amid recent macroeconomic data and a weak jobs report.

7 de ago. de 2026, 23:56 UTC

Correlated Moves

Albany International Corp shares are higher in after-market trading, supported by broader market dynamics and decreased interest rate hike expectations following a weak jobs report.

Comparação entre Pares

Variação de preço

Travere Therapeutics Inc Previsão

Preço-alvo

By TipRanks

15.69% parte superior

Previsão para 12 meses

Média 72.25 USD 15.69%

Máximo 90 USD

Mínimo 49 USD

Com base em 12 analistas de Wall Street que oferecem metas de preço de 12 meses para Travere Therapeutics Inc - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Compra Forte

12 ratings

Comprar

Manter

Vender

Com base em 12 analistas que deram avaliações de ações para Travere Therapeutics Inc - Dist nos últimos 3 meses.

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

Sobre Travere Therapeutics Inc

Travere Therapeutics, Inc., a biopharmaceutical company, identifies, develops, and delivers therapies to people living with rare kidney and metabolic diseases. Its products include FILSPARI (sparsentan), a once-daily, oral medication designed to target two critical pathways in the disease progression of IgA Nephropathy (endothelin 1 and angiotensin-II); and Thiola and Thiola EC (tiopronin tablets) for the treatment of cystinuria, a rare genetic cystine transport disorder that causes high cystine levels in the urine and the formation of recurring kidney stones. The company's clinical-stage programs consist of Sparsentan, a novel investigational product candidate, which has been granted Orphan Drug Designation for the treatment of focal segmental glomerulosclerosis in the U.S. and Europe; and Pegtibatinase (TVT-058), a novel investigational human enzyme replacement candidate being evaluated for the treatment of classical homocystinuria. It has a cooperative research and development agreement with National Institutes of Health's National Center for Advancing Translational Sciences and Alagille Syndrome Alliance for the identification of potential small molecule therapeutics for Alagille syndrome. The company was formerly known as Retrophin, Inc. and changed its name to Travere Therapeutics, Inc. in November 2020. Travere Therapeutics, Inc. was incorporated in 2008 and is headquartered in San Diego, California.